What does CUSIP 74366E102 represent in this 13F holders report?

CUSIP 74366E102 is the security identifier for PTGX - Protagonist Therapeutics, Inc - Common Stock used to aggregate holder disclosures.

How many institutions held PTGX - Protagonist Therapeutics, Inc - Common Stock in Q1 2017?

39 institutional investors reported PTGX - Protagonist Therapeutics, Inc - Common Stock for Q1 2017. Use the holders table for investor-level position and value details.

Protagonist Therapeutics, Inc - Common Stock (PTGX)

CUSIP: 74366E102

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / Common Stock
Shares outstanding: 63,850,747
Total 13F shares: 8,008,863
Share change: +382,135
Total reported value: $102,590,269
Price per share: $12.81
Number of holders: 39
Value change: +$4,468,821
Number of buys: 17
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 74366E102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	3.9%	2,507,167	$55,133,000	—	31 Dec 2016	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.4%	1,531,076	$33,668,000	—	31 Dec 2016	13F
Pharmstandard International S.A.	13F	Company	1.5%	983,570	$21,628,000	—	31 Dec 2016	13F
Cormorant Asset Management, LP	13F	Company	1.1%	720,000	$15,833,000	—	31 Dec 2016	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.1%	692,563	$14,634,000	—	31 Dec 2016	13F
Foresite Capital Management III, LLC	13F	Company	0.54%	346,281	$7,615,000	—	31 Dec 2016	13F
VANGUARD GROUP INC	13F	Company	0.49%	310,079	$6,818,000	—	31 Dec 2016	13F
BlackRock Fund Advisors	13F	Company	0.38%	244,386	$5,374,000	—	31 Dec 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	99,368	$2,185,000	—	31 Dec 2016	13F
STATE STREET CORP	13F	Company	0.14%	92,163	$2,028,000	—	31 Dec 2016	13F
NORTHERN TRUST CORP	13F	Company	0.13%	82,180	$1,807,000	—	31 Dec 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.11%	72,987	$1,605,000	—	31 Dec 2016	13F
DAFNA Capital Management LLC	13F	Company	0.07%	45,586	$1,002,000	—	31 Dec 2016	13F
Graticule Asia Macro Advisors LLC	13F	Company	0.05%	31,827	$700,000	—	31 Dec 2016	13F
Spark Investment Management LLC	13F	Company	0.05%	31,500	$692,000	—	31 Dec 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.05%	29,930	$658,000	—	31 Dec 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.04%	22,918	$504,000	—	31 Dec 2016	13F
MORGAN STANLEY	13F	Company	0.04%	22,778	$501,000	—	31 Dec 2016	13F
Bank of New York Mellon Corp	13F	Company	0.04%	22,715	$500,000	—	31 Dec 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	15,700	$345,000	—	31 Dec 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	13,200	$291,000	—	31 Dec 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	10,610	$233,000	—	31 Dec 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	9,461	$208,000	—	31 Dec 2016	13F
CITIGROUP INC	13F	Company	0.01%	7,638	$168,000	—	31 Dec 2016	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	5,746	$126,000	—	31 Dec 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	5,219	$115,000	—	31 Dec 2016	13F
Nationwide Fund Advisors	13F	Company	0.01%	4,934	$108,000	—	31 Dec 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	4,343	$94,000	—	31 Dec 2016	13F
BLACKROCK ADVISORS LLC	13F	Company	0%	2,758	$61,000	—	31 Dec 2016	13F
STRS OHIO	13F	Company	0%	2,400	$52,000	—	31 Dec 2016	13F
UBS Group AG	13F	Company	0%	1,443	$32,000	—	31 Dec 2016	13F
Legal & General Group Plc	13F	Company	0%	1,343	$30,000	—	31 Dec 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,043	$23,000	—	31 Dec 2016	13F
Creative Planning	13F	Company	0%	677	$15,000	—	31 Dec 2016	13F
ROYAL BANK OF CANADA	13F	Company	0%	357	$8,000	—	31 Dec 2016	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	363	$7,982	—	31 Dec 2016	13F
BlackRock Finance, Inc.	13F	Company	0%	262	$6,000	—	31 Dec 2016	13F
BARCLAYS PLC	13F	Company	0%	218	$5,000	—	31 Dec 2016	13F

Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q1 2017

As of 31 Mar 2017, Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,008,863 shares. The largest 10 holders included FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pharmstandard International S.A., Cormorant Asset Management, LLC, RA CAPITAL MANAGEMENT, LLC, Foresite Capital Management III, LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders

Q1 2017 holders

Holder diff

Investor	Q4 2016 Shares	Q1 2017 Shares	Share Diff	Share Chg %	Q4 2016 Value $	Q1 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.